One-third of people classified as ‘highest risk’ may not develop Alzheimer’s disease, study suggests.
ACT studies find medications to treat high blood pressure may differ in their impact on dementia risk, writes Dr. Eric B. Larson.
Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
$40.5M NIH-funded project aims to pinpoint cells at root of brain disease—and new therapeutic targets.
Dr. Larson reflects on splashes, ripples, and new research, which builds on his earlier findings from the ACT study.
Dr. Rob Penfold leads pragmatic trial of new online version of proven program developed by UW colleagues.
A study shows central nervous system-active drugs may increase risk of falling in people with dementia.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.